Many Americans Worry About the Safety of COVID Biologics
A new poll conducted Yahoo! News/YouGov during July 13-15, 2021 found that 37 percent of unvaccinated Americans are more fearful of the three experimental COVID-19 biologics currently available in the United States than they are of the SARS-CoV-2 virus that can cause the disease. The survey of 1,715 adults in the U.S. found that only […]
COVID-19 Vaccine Skeptics Have Many Concerns
With close to one-third of adults in the United States choosing to delay or forego the experimental COVID-19 vaccines, the medical industry is reportedly trying to understand the reasons behind the hesitancy and figure out how to persuade more Americans to get vaccinated.
Johnson & Johnson Recalls Carcinogen Containing Sunscreen Products
On July 14, 2021, Johnson and Johnson Consumer, Inc. voluntarily recalled all batches of five NEUTROGENA and AVEENO aerosol sunscreen product lines distributed to consumers through a variety of retail channels. The corporation recalled the products after a cancer causing chemical known as benzene was detected in samples. The products were distributed nationwide and Johnson […]
FDA Adds Warning About Rare Reaction to J&J COVID-19 Vaccine
As the state sends mobile units from town to town to increase vaccination rates, the Johnson & Johnson shot is causing more worries. The FDA is now warning of a potential increased risk of a nerve complication called Guillain-Barré syndrome. Doctors say the roughly 100 cases reported after nearly 13 million shots should not be […]
Journal Article Questioning COVID Vaccination Protocols Retracted
A scholarly article published in a medical journal, in which authors concluded that a “lack of clear benefit should cause governments to rethink their vaccination policy,” has been retracted less than two weeks after publication. The article entitled “The Safety of COVID-19 Vaccinations—We Should Rethink the Policy” was published by MDPI (Multidisciplinary Digital Publishing Institute) […]
Pfizer Plan for COVID Booster Shot Raises Safety Concerns
Opinion | On July 8, 2021, Pfizer, Inc. announced it was developing a booster dose for its experimental messenger RNA (mRNA) BNT162b2 biologic for COVID-19. It said that it had observed waning immunity among people who received the standard two-dose regimen of the product. The company said it planned to begin clinical studies of the […]
